These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
595 related articles for article (PubMed ID: 26165422)
1. Folate-modified, cisplatin-loaded lipid carriers for cervical cancer chemotherapy. Zhang G; Liu F; Jia E; Jia L; Zhang Y Drug Deliv; 2016 May; 23(4):1393-7. PubMed ID: 26165422 [TBL] [Abstract][Full Text] [Related]
2. Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy. Lin M; Teng L; Wang Y; Zhang J; Sun X Drug Deliv; 2016 May; 23(4):1420-5. PubMed ID: 26203688 [TBL] [Abstract][Full Text] [Related]
3. Targeted delivery of etoposide to cancer cells by folate-modified nanostructured lipid drug delivery system. Zhang S; Lu C; Zhang X; Li J; Jiang H Drug Deliv; 2016 Jun; 23(5):1838-45. PubMed ID: 26879035 [TBL] [Abstract][Full Text] [Related]
4. Novel RGD containing, temozolomide-loading nanostructured lipid carriers for glioblastoma multiforme chemotherapy. Song S; Mao G; Du J; Zhu X Drug Deliv; 2016 May; 23(4):1404-8. PubMed ID: 26203687 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo evaluation of folate-mediated PEGylated nanostructured lipid carriers for the efficient delivery of furanodiene. Zhang J; He Y; Jiang J; Li M; Jin C; Wang L; Wang D Drug Dev Ind Pharm; 2017 Oct; 43(10):1610-1618. PubMed ID: 28481661 [TBL] [Abstract][Full Text] [Related]
6. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy? Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462 [TBL] [Abstract][Full Text] [Related]
8. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer. Li C; Ge X; Wang L Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539 [TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers based temozolomide and gene co-encapsulated nanomedicine for gliomatosis cerebri combination therapy. Chen Z; Lai X; Song S; Zhu X; Zhu J Drug Deliv; 2016 May; 23(4):1369-73. PubMed ID: 26017099 [TBL] [Abstract][Full Text] [Related]
10. Cisplatin and paclitaxel co-delivered by folate-decorated lipid carriers for the treatment of head and neck cancer. Yang J; Ju Z; Dong S Drug Deliv; 2016 Nov; 24(1):792-799. PubMed ID: 28494629 [TBL] [Abstract][Full Text] [Related]
11. Oxaprozin-Loaded Lipid Nanoparticles towards Overcoming NSAIDs Side-Effects. Lopes-de-Araújo J; Neves AR; Gouveia VM; Moura CC; Nunes C; Reis S Pharm Res; 2016 Feb; 33(2):301-14. PubMed ID: 26350105 [TBL] [Abstract][Full Text] [Related]
12. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery. Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic effect of folate-targeted and PEGylated phytosomes loaded with a mitomycin C-soybean phosphatidyhlcholine complex. Li Y; Wu H; Jia M; Cui F; Lin J; Yang X; Wang Y; Dai L; Hou Z Mol Pharm; 2014 Sep; 11(9):3017-26. PubMed ID: 25054963 [TBL] [Abstract][Full Text] [Related]
14. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice. Li H; Li Y; Ao H; Bi D; Han M; Guo Y; Wang X Drug Deliv; 2018 Nov; 25(1):880-887. PubMed ID: 29608108 [TBL] [Abstract][Full Text] [Related]
15. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice. Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional transactivator peptide modified lidocaine-loaded nanoparticulate drug delivery system for topical anesthetic therapy. Wang Y; Wang S; Shi P Drug Deliv; 2016 Nov; 23(9):3193-3199. PubMed ID: 27045388 [TBL] [Abstract][Full Text] [Related]
17. Lung cancer gene therapy: Transferrin and hyaluronic acid dual ligand-decorated novel lipid carriers for targeted gene delivery. Zhang B; Zhang Y; Yu D Oncol Rep; 2017 Feb; 37(2):937-944. PubMed ID: 27959442 [TBL] [Abstract][Full Text] [Related]
18. Characterization and evaluation of nanostructured lipid carrier as a vehicle for oral delivery of etoposide. Zhang T; Chen J; Zhang Y; Shen Q; Pan W Eur J Pharm Sci; 2011 Jun; 43(3):174-9. PubMed ID: 21530654 [TBL] [Abstract][Full Text] [Related]
19. Folate and Pegylated Aliphatic Polyester Nanoparticles for Targeted Anticancer Drug Delivery. Tsolou A; Angelou E; Didaskalou S; Bikiaris D; Avgoustakis K; Agianian B; Koffa MD Int J Nanomedicine; 2020; 15():4899-4918. PubMed ID: 32764924 [TBL] [Abstract][Full Text] [Related]
20. Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Su Z; Niu J; Xiao Y; Ping Q; Sun M; Huang A; You W; Sang X; Yuan D Mol Pharm; 2011 Oct; 8(5):1641-51. PubMed ID: 21770405 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]